Leike Zhang

47PUBLICATIONS
116CO-AUTHORS
PharmacogenomicsMedical virologyMedical infection agents (incl. prions)Characterisation of biological macromoleculesCauses and prevention of crime
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (47)

|Apr 27, 2026
SARS-CoV-2 3CLpro mutations T21I and E166A confer differential resistance to simnotrelvir, bofutrelvir, and ensitrelvir.

|Apr 21, 2026
The oral nucleoside analogue inhibitor VV251 effectively inhibits coinfection by respiratory syncytial virus and influenza A virus.

|Mar 26, 2026
Severe fever with thrombocytopenia syndrome virus infection of the male reproductive tract induces pathology and inflammation.

Yunfa Zhang, Lingyu Zhang, Huan Xu

|Mar 11, 2026
A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.

Zhengyu Ye, Wenhao Dai, Shaolin Zhang

|Feb 10, 2026
Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus.

Yumin Zhang, Sheng Tang, Lu Chen

|Nov 25, 2025
Oral VV261 administration protects mice from lethal Crimean-Congo hemorrhagic fever virus challenge.

Xi Wang, Huan Xu, Liushuai Li

Pageof 8

Frequent Collaborators

11 joint publications

Yumin Zhang

10 joint publications

Gengfu Xiao

10 joint publications

Jingshan Shen

8 joint publications

Hong Liu